AK

Akinchan Kushwaha

Active Director Director DIN 09762764
DIN 09762764 First appointment Oct 2022 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Akinchan Kushwaha

Data last updated:

Akinchan Kushwaha is a Director at Akac Healthcare Private Limited (since 2022). The company operates in Healthcare.

DIN 09762764
Primary Designation Director
Industry Healthcare
First Appointment 12 Oct 2022
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Akac Healthcare Private Limited U85194DL2022PTC405748
Director12 Oct 20222022Active

Board colleagues of Akinchan Kushwaha

NameDINCompanyDesignation
Ananay Chahal09762765Akac Healthcare Private LimitedDirector
Vishva Raj10190050Akac Healthcare Private LimitedDirector

Directorship timeline

Open interactive timeline →
Akac Healthcare Private Limited
Premium access

Shareholding and investment profile for Akinchan Kushwaha

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Akinchan Kushwaha

Akinchan Kushwaha currently holds 1 directorship: Akac Healthcare Private Limited (Director, since 12 Oct 2022).

Akinchan Kushwaha was first appointed on 12 Oct 2022 as Director at Akac Healthcare Private Limited.

The current boards of Akinchan Kushwaha's companies include Ananay Chahal (Akac Healthcare Private Limited), Vishva Raj (Akac Healthcare Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available